Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Up 747.5% in December

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 222,900 shares, a growth of 747.5% from the November 30th total of 26,300 shares. Based on an average daily volume of 1,352,700 shares, the short-interest ratio is currently 0.2 days.

Ono Pharmaceutical Trading Down 1.5 %

Ono Pharmaceutical stock traded down $0.05 during midday trading on Thursday, reaching $3.36. The company had a trading volume of 757,296 shares, compared to its average volume of 239,843. Ono Pharmaceutical has a 12-month low of $3.27 and a 12-month high of $6.11. The firm’s fifty day simple moving average is $3.89 and its 200-day simple moving average is $4.38.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.